| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00057 |
1 |
| mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
-0.0005 |
1 |
| mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.00056 |
1 |
| mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.00066 |
1 |
| mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
0.00036 |
1 |
| mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
0.0002 |
1 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00016 |
1 |
| mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
-0.0002 |
1 |
| mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.00016 |
1 |
| mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
8.7e-05 |
1 |